Stockscreener 앱 받기
3.43
17.15%
-0.71
전일 마감가:
$4.14
열려 있는:
$4
하루 거래량:
341.27K
Relative Volume:
0.13
시가총액:
$6.57M
수익:
-
순이익/손실:
$-5.00M
주가수익비율:
-2.9826
EPS:
-1.15
순현금흐름:
$-3.85M
1주 성능:
-21.15%
1개월 성능:
-4.72%
6개월 성능:
+25.58%
1년 성능:
-60.95%
1일 변동 폭
$3.28
$4.07
1주일 범위
$3.28
$4.43
52주 변동 폭
$2.25
$15.26
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
명칭
Protagenic Therapeutics Inc
전화
(212) 994-8200
주소
149 FIFTH AVENUE, NEW YORK
PTIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
3.43 | 7.93M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc 주식(PTIX)의 최신 뉴스
Measuring Protagenic Therapeutics Inc.’s beta against major indicesWeekly Market Summary & Reliable Intraday Trade Alerts - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock outperform energy sector in 20252025 Market Overview & Trade Opportunity Analysis - newser.com
Applying Wyckoff theory to Protagenic Therapeutics Inc. Equity Warrant stockStop Loss & Weekly Sector Rotation Insights - newser.com
Can Protagenic Therapeutics Inc. Equity Warrant stock deliver sustainable ROEWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com
Is Protagenic Therapeutics Inc. stock a good choice for value investorsJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Protagenic Therapeutics Inc Stock Analysis and ForecastDay Trading Setups & Minimal Risk High Reward - earlytimes.in
How moving averages guide Protagenic Therapeutics Inc. Equity Warrant tradingQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
Using Bollinger Bands to evaluate Protagenic Therapeutics Inc.July 2025 Retail & Verified Short-Term Plans - newser.com
Will Protagenic Therapeutics Inc. stock outperform Dow Jones index2025 Risk Factors & Safe Capital Allocation Plans - newser.com
What the charts say about Protagenic Therapeutics Inc. Equity Warrant today2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Why institutional investors increase stakes in Protagenic Therapeutics Inc. (MBP0) stockEarnings Growth Report & Consistent Profit Trading Strategies - newser.com
What drives Protagenic Therapeutics Inc stock priceInsider Trading Compliance & Budget Friendly Portfolio - earlytimes.in
Pattern recognition hints at Protagenic Therapeutics Inc. upsideJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
Published on: 2025-09-30 00:57:35 - newser.com
Will Protagenic Therapeutics Inc. (MBP0) stock announce special dividend2025 Biggest Moves & Step-by-Step Swing Trade Plans - newser.com
Does Protagenic Therapeutics Inc. Equity Warrant qualify in momentum factor screeningJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - newser.com
Will Protagenic Therapeutics Inc. Equity Warrant stock outperform tech sector in 2025Sell Signal & Technical Pattern Recognition Alerts - newser.com
Can Protagenic Therapeutics Inc. stock surprise with earnings upsideJuly 2025 Technicals & Verified Momentum Stock Watchlist - newser.com
Volatility clustering patterns for Protagenic Therapeutics Inc.2025 Analyst Calls & Weekly High Return Forecasts - newser.com
Chart based exit strategy for Protagenic Therapeutics Inc.Exit Point & Momentum Based Trading Ideas - newser.com
Tick level data insight on Protagenic Therapeutics Inc. Equity Warrant volatility2025 Market Outlook & Reliable Breakout Forecasts - newser.com
Published on: 2025-09-29 04:14:17 - newser.com
Why Protagenic Therapeutics Inc. Equity Warrant stock could be next big winnerJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
Protagenic Therapeutics Inc (PTIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
1.10%
자본화:
|
볼륨(24시간):